- Entry
- $13.04
- Now
- $15.90 +21.9%
- Target
- —
- Score
- —
TLDR: PSNL has very limited downside risk (low single digit %) due to an earlier merger agreement with Tempus and yet potentially triple digit % return if the merger deal is to fall through, which looks increasingly likely after the Moderna cancer vaccine update - especially after considering the stock has been trading ABOVE the buyout price consistently for 2 weeks with almost 50% of outstanding shares traded above that level. Personalis, a tiny and very little known company, powers …
— ORIGINAL POST ·
PSNL looks like an opportunity with limited downside yet substantial upside if the Tempus merger falls through
· r/investing
· Sep 3, 2026